USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Aug 8, 2022 | Jun 2022 | $0.58 | - | $0.66 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Aug 8, 2022 | Jun 2022 | $143.11M | - | $136.46M |
Halozyme Therapeutics, Inc's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Jun 2022 | 7 | $0.58 | $0.49 | $0.77 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 10 | $2.18 | $2.06 | $2.42 |
| Dec 2023 | 8 | $2.80 | $2.12 | $3.23 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Jun 2022 | 1 / 0 | $0.54 | $0.59 | $0.75 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 1 / 0 | $2.16 | $2.22 | $2.68 |
| Dec 2023 | 1 / 0 | $2.80 | $2.86 | $3.28 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Jun 2022 | 8 | $143.11M | $131.12M | $177.20M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 11 | $553.27M | $540.85M | $590.60M |
| Dec 2023 | 9 | $671.96M | $563.90M | $756.58M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| May 9, 2022 | Mar 2022 | $0.48 | - | - |
| Feb 22, 2022 | Dec 2021 | $0.41 | $0.42 | 2.44% |
| Nov 2, 2021 | Sep 2021 | $0.48 | $0.55 | 15.67% |
| Aug 9, 2021 | Jun 2021 | $0.44 | $0.66 | 51.45% |
| May 10, 2021 | Mar 2021 | $0.31 | $0.37 | 18.59% |
| Feb 23, 2021 | Dec 2020 | $0.54 | $0.50 | -7.42% |
| Nov 2, 2020 | Sep 2020 | $0.21 | $0.25 | 21.89% |
| Aug 10, 2020 | Jun 2020 | $0.25 | $0.19 | -22.83% |
| May 11, 2020 | Mar 2020 | $-0.04 | $-0.04 | -3.63% |
| Feb 24, 2020 | Dec 2019 | $-0.14 | $-0.24 | -67.60% |
| Nov 12, 2019 | Sep 2019 | $-0.13 | $-0.17 | -33.12% |
| Aug 6, 2019 | Jun 2019 | $-0.15 | $-0.10 | 33.73% |
| May 7, 2019 | Mar 2019 | $0.05 | $0.01 | -78.26% |
| Feb 21, 2019 | Dec 2018 | $-0.03 | $-0.01 | 60.16% |
| Nov 6, 2018 | Sep 2018 | $-0.23 | $-0.19 | 15.67% |
| Aug 7, 2018 | Jun 2018 | $-0.22 | $-0.16 | 25.65% |
| May 10, 2018 | Mar 2018 | $-0.22 | $-0.19 | 14.34% |
| Feb 20, 2018 | Dec 2017 | $0.77 | $0.85 | 11.05% |
| Nov 7, 2017 | Sep 2017 | $-0.11 | $0.02 | 118.18% |
| Aug 8, 2017 | Jun 2017 | $-0.24 | $-0.23 | 5.54% |
| May 9, 2017 | Mar 2017 | $-0.24 | $-0.26 | -6.34% |
| Feb 28, 2017 | Dec 2016 | $-0.30 | $-0.21 | 29.48% |
| Nov 7, 2016 | Sep 2016 | $-0.26 | $-0.23 | 13.04% |
| Aug 9, 2016 | Jun 2016 | $-0.28 | $-0.21 | 26.11% |
| May 9, 2016 | Mar 2016 | $-0.22 | $-0.16 | 26.84% |
| Feb 29, 2016 | Dec 2015 | $-0.03 | $0.03 | 199.01% |
| Nov 9, 2015 | Sep 2015 | $-0.16 | $-0.19 | -18.75% |
| Aug 10, 2015 | Jun 2015 | $-0.09 | $0.02 | 122.22% |
| May 11, 2015 | Mar 2015 | $-0.13 | $-0.12 | 7.69% |
| Mar 2, 2015 | Dec 2014 | $-0.06 | $-0.04 | 33.33% |
| Nov 10, 2014 | Sep 2014 | $-0.14 | $-0.16 | -14.29% |
| Aug 11, 2014 | Jun 2014 | $-0.14 | $-0.13 | 7.14% |
| May 12, 2014 | Mar 2014 | $-0.14 | $-0.22 | -57.14% |
| Feb 27, 2014 | Dec 2013 | $-0.16 | $-0.19 | -18.75% |
| Nov 8, 2013 | Sep 2013 | $-0.15 | $-0.17 | -13.33% |
| Aug 7, 2013 | Jun 2013 | $-0.13 | $-0.20 | -53.85% |
| May 8, 2013 | Mar 2013 | $-0.15 | $-0.17 | -13.33% |
| Feb 25, 2013 | Dec 2012 | $-0.15 | $-0.04 | 73.33% |
| Nov 8, 2012 | Sep 2012 | $-0.14 | $-0.18 | -28.57% |
| Aug 6, 2012 | Jun 2012 | $-0.15 | $-0.13 | 13.33% |
| May 7, 2012 | Mar 2012 | $-0.11 | $-0.14 | -27.27% |
| Mar 9, 2012 | Dec 2011 | $-0.15 | $-0.18 | -20.00% |
| Nov 7, 2011 | Sep 2011 | $-0.04 | $0.05 | 225.00% |
| Aug 5, 2011 | Jun 2011 | $-0.13 | $0.03 | 123.08% |
| May 6, 2011 | Mar 2011 | $-0.12 | $-0.10 | 16.67% |
| Mar 11, 2011 | Dec 2010 | - | $-0.17 | - |
| Nov 5, 2010 | Sep 2010 | $-0.14 | $-0.13 | 7.14% |
| Aug 6, 2010 | Jun 2010 | $-0.14 | $-0.13 | 7.14% |
| May 7, 2010 | Mar 2010 | $-0.16 | $-0.13 | 18.75% |
| Mar 12, 2010 | Dec 2009 | $-0.17 | $-0.14 | 17.65% |
| Nov 6, 2009 | Sep 2009 | $-0.18 | $-0.16 | 11.11% |
| Aug 7, 2009 | Jun 2009 | $-0.17 | $-0.21 | -23.53% |
| May 8, 2009 | Mar 2009 | $-0.16 | $-0.18 | -12.50% |
| Mar 13, 2009 | Dec 2008 | $-0.13 | $-0.21 | -61.54% |
| Nov 6, 2008 | Sep 2008 | $-0.13 | $-0.14 | -7.69% |
| Aug 8, 2008 | Jun 2008 | $-0.13 | $-0.14 | -7.69% |
| May 8, 2008 | Mar 2008 | $-0.12 | $-0.13 | -8.33% |
| Mar 13, 2008 | Dec 2007 | $-0.08 | $-0.11 | -37.50% |
| Nov 8, 2007 | Sep 2007 | $-0.06 | $-0.09 | -50.00% |
| Aug 9, 2007 | Jun 2007 | $-0.04 | $-0.07 | -75.00% |
| May 10, 2007 | Mar 2007 | $-0.05 | $-0.05 | - |
| Mar 8, 2007 | Dec 2006 | $-0.06 | $-0.07 | -16.67% |
| Nov 9, 2006 | Sep 2006 | $-0.06 | $-0.06 | - |
| Aug 10, 2006 | Jun 2006 | $-0.05 | $-0.05 | - |
| May 10, 2006 | Mar 2006 | $-0.05 | $-0.06 | -20.00% |
| Mar 23, 2006 | Dec 2005 | $-0.06 | $-0.07 | -16.67% |
| Nov 11, 2005 | Sep 2005 | $-0.06 | $-0.07 | -16.67% |
| Aug 8, 2005 | Jun 2005 | $-0.06 | $-0.06 | - |
| May 13, 2005 | Mar 2005 | $-0.06 | $-0.06 | - |
| Mar 9, 2005 | Dec 2004 | $-0.07 | $-0.05 | 28.57% |
| Nov 12, 2004 | Sep 2004 | $-0.05 | $-0.08 | -60.00% |
| Aug 16, 2004 | Jun 2004 | $-0.04 | $-0.05 | -25.00% |
| Jun 1, 2004 | Mar 2004 | $-0.03 | $-0.08 | -177.33% |
| Mar 30, 2004 | Dec 2003 | - | $-0.01 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 22, 2022 | Dec 2021 | $1.97 | $2.00 | 1.52% |
| Feb 23, 2021 | Dec 2020 | $0.93 | $0.90 | -3.23% |
| Feb 24, 2020 | Dec 2019 | $-0.41 | $-0.50 | - |
| Feb 21, 2019 | Dec 2018 | $-0.57 | $-0.55 | - |
| Feb 20, 2018 | Dec 2017 | $0.32 | $0.38 | 18.75% |
| Feb 28, 2017 | Dec 2016 | - | $-0.81 | - |
| Feb 29, 2016 | Dec 2015 | - | $-0.26 | - |
| Mar 2, 2015 | Dec 2014 | - | $-0.55 | - |
| Feb 27, 2014 | Dec 2013 | - | $-0.73 | - |
| Feb 25, 2013 | Dec 2012 | - | $-0.49 | - |
| Mar 9, 2012 | Dec 2011 | - | $-0.20 | - |
| Mar 11, 2011 | Dec 2010 | - | $-0.56 | - |
| Mar 12, 2010 | Dec 2009 | - | $-0.69 | - |
| Mar 13, 2009 | Dec 2008 | - | $-0.62 | - |
| Mar 13, 2008 | Dec 2007 | - | $-0.32 | - |
| Mar 8, 2007 | Dec 2006 | - | $-0.24 | - |
| Mar 23, 2006 | Dec 2005 | - | $-0.26 | - |
| Mar 9, 2005 | Dec 2004 | - | $-0.26 | - |
| Mar 30, 2004 | Dec 2003 | - | $-0.01 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| May 9, 2022 | Mar 2022 | $126.50M | - | - |
| Feb 22, 2022 | Dec 2021 | $100.32M | $102.00M | 1.02% |
| Nov 2, 2021 | Sep 2021 | $0.00 | $115.83M | - |
| Aug 9, 2021 | Jun 2021 | $104.04M | $136.46M | 1.31% |
| May 10, 2021 | Mar 2021 | $84.88M | $89.02M | 1.05% |
| Feb 23, 2021 | Dec 2020 | $120.16M | $121.70M | 1.01% |
| Nov 2, 2020 | Sep 2020 | $60.90M | $65.32M | 1.07% |
| Aug 10, 2020 | Jun 2020 | $66.68M | $55.22M | 0.83% |
| May 11, 2020 | Mar 2020 | $42.96M | $25.35M | 0.59% |
| Feb 24, 2020 | Dec 2019 | $56.93M | $53.66M | 0.94% |
| Nov 12, 2019 | Sep 2019 | $54.93M | $46.23M | 0.84% |
| Aug 6, 2019 | Jun 2019 | $42.56M | $39.15M | 0.92% |
| May 7, 2019 | Mar 2019 | $67.80M | $56.95M | 0.84% |
| Feb 21, 2019 | Dec 2018 | $59.77M | $60.23M | 1.01% |
| Nov 6, 2018 | Sep 2018 | $30.42M | $25.56M | 0.84% |
| Aug 7, 2018 | Jun 2018 | $30.09M | $35.20M | 1.17% |
| May 10, 2018 | Mar 2018 | $31.43M | $30.87M | 0.98% |
| Feb 20, 2018 | Dec 2017 | $165.19M | $189.56M | 1.15% |
| Nov 7, 2017 | Sep 2017 | $58.95M | $63.73M | 1.08% |
| Aug 8, 2017 | Jun 2017 | $31.56M | $33.75M | 1.07% |
| May 9, 2017 | Mar 2017 | - | $29.57M | - |
| Feb 28, 2017 | Dec 2016 | - | $39.00M | - |
| Nov 7, 2016 | Sep 2016 | - | $31.85M | - |
| Aug 9, 2016 | Jun 2016 | - | $33.34M | - |
| May 9, 2016 | Mar 2016 | - | $42.50M | - |
| Feb 29, 2016 | Dec 2015 | - | $52.23M | - |
| Nov 9, 2015 | Sep 2015 | - | $20.78M | - |
| Aug 10, 2015 | Jun 2015 | - | $43.38M | - |
| May 11, 2015 | Mar 2015 | - | $18.67M | - |
| Mar 2, 2015 | Dec 2014 | - | $30.38M | - |
| Nov 10, 2014 | Sep 2014 | - | $14.61M | - |
| Aug 11, 2014 | Jun 2014 | - | $18.39M | - |
| May 12, 2014 | Mar 2014 | - | $11.97M | - |
| Feb 27, 2014 | Dec 2013 | - | $12.50M | - |
| Nov 8, 2013 | Sep 2013 | - | $16.01M | - |
| Aug 7, 2013 | Jun 2013 | - | $14.45M | - |
| May 8, 2013 | Mar 2013 | - | $11.83M | - |
| Feb 25, 2013 | Dec 2012 | - | $21.79M | - |
| Nov 8, 2012 | Sep 2012 | - | $5.33M | - |
| Aug 6, 2012 | Jun 2012 | - | $7.76M | - |
| May 7, 2012 | Mar 2012 | - | $7.44M | - |
| Mar 9, 2012 | Dec 2011 | - | $2.41M | - |
| Nov 7, 2011 | Sep 2011 | - | $22.94M | - |
| Aug 5, 2011 | Jun 2011 | - | $23.19M | - |
| May 6, 2011 | Mar 2011 | - | $7.54M | - |
| Mar 11, 2011 | Dec 2010 | - | $3.57M | - |
| Nov 5, 2010 | Sep 2010 | - | $3.40M | - |
| Aug 6, 2010 | Jun 2010 | - | $3.21M | - |
| May 7, 2010 | Mar 2010 | - | $3.44M | - |
| Mar 12, 2010 | Dec 2009 | - | $6.44M | - |
| Nov 6, 2009 | Sep 2009 | - | $3.03M | - |
| Aug 7, 2009 | Jun 2009 | - | $1.43M | - |
| May 8, 2009 | Mar 2009 | - | $2.77M | - |
| Mar 13, 2009 | Dec 2008 | - | $3.06M | - |
| Nov 6, 2008 | Sep 2008 | - | $2.46M | - |
| Aug 8, 2008 | Jun 2008 | - | $1.43M | - |
| May 8, 2008 | Mar 2008 | - | $1.81M | - |
| Mar 13, 2008 | Dec 2007 | - | $1.34M | - |
| Nov 8, 2007 | Sep 2007 | - | $942.88K | - |
| Aug 9, 2007 | Jun 2007 | - | $708.52K | - |
| May 10, 2007 | Mar 2007 | - | $810.22K | - |
| Mar 8, 2007 | Dec 2006 | - | $426.33K | - |
| Nov 9, 2006 | Sep 2006 | - | $362.48K | - |
| Aug 10, 2006 | Jun 2006 | - | $119.66K | - |
| May 10, 2006 | Mar 2006 | - | $73.28K | - |
| Mar 23, 2006 | Dec 2005 | - | $55.86K | - |
| Nov 11, 2005 | Sep 2005 | - | $25.64K | - |
| Aug 8, 2005 | Jun 2005 | - | $45.70K | - |
| May 13, 2005 | Mar 2005 | - | $0.00 | - |
| Mar 9, 2005 | Dec 2004 | - | $0.00 | - |
| Nov 12, 2004 | Sep 2004 | - | $0.00 | - |
| Aug 16, 2004 | Jun 2004 | - | $0.00 | - |
| Jun 1, 2004 | Mar 2004 | - | $0.00 | - |
| Mar 30, 2004 | Dec 2003 | - | $2.32K | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 22, 2022 | Dec 2021 | $441.33M | $443.31M | 0.45% |
| Feb 23, 2021 | Dec 2020 | $265.37M | $267.59M | 0.84% |
| Feb 24, 2020 | Dec 2019 | $199.36M | $195.99M | -1.69% |
| Feb 21, 2019 | Dec 2018 | $151.34M | $151.86M | 0.34% |
| Feb 20, 2018 | Dec 2017 | $296.84M | $316.61M | 6.66% |
| Feb 28, 2017 | Dec 2016 | - | $146.69M | - |
| Feb 29, 2016 | Dec 2015 | - | $135.06M | - |
| Mar 2, 2015 | Dec 2014 | - | $75.33M | - |
| Feb 27, 2014 | Dec 2013 | - | $54.80M | - |
| Feb 25, 2013 | Dec 2012 | - | $42.33M | - |
| Mar 9, 2012 | Dec 2011 | - | $56.09M | - |
| Mar 11, 2011 | Dec 2010 | - | $13.62M | - |
| Mar 12, 2010 | Dec 2009 | - | $13.67M | - |
| Mar 13, 2009 | Dec 2008 | - | $8.76M | - |
| Mar 13, 2008 | Dec 2007 | - | $3.80M | - |
| Mar 8, 2007 | Dec 2006 | - | $981.75K | - |
| Mar 23, 2006 | Dec 2005 | - | $127.21K | - |
| Mar 9, 2005 | Dec 2004 | - | - | - |
| Mar 30, 2004 | Dec 2003 | - | $25.70K | - |
HALO's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 30, 2022.
According to analysts, the average EPS estimation for Halozyme Therapeutics, Inc's next quarterly earnings is $0.58, with a low EPS estimation of $0.49, and a high estimation of $0.77.
Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $0.54, the last 2 month trend is $0.59, and the 3 month trend is $0.75.
Based on analysts, the average revenue estimation is $143.11M, with a low revenue estimation of $131.12M, and a high estimation of $177.20M.
Halozyme Therapeutics, Inc's previous earnings date was May 9, 2022 for its fiscal quarter ended Mar 31, 2022.
Halozyme Therapeutics, Inc's previous annual earnings date was Feb 22, 2022 for its fiscal year ended Dec 31, 2021.
HALO's earnings per share (EPS) was $2.00, beating the consensus analysts forecast of $1.97 by 1.52% , and higher than the previous year's EPS (Dec 2020) by 122.22%.
Revenues were $443.31M, better than the forecast of $441.33M by 0.45%, and up by 65.67% from previous year's revenue.
The company reported a net income of $402.71M, 211.97% higher than the previous year.
Halozyme Therapeutics, Inc reported a free cash flow of $297.98M for its fiscal year, compared to $52.95M a year ago.
The company ended the fiscal year with $876.67M in total debt, an increase of 120.70% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
